The role of selected risk factors in Barrett's esophagus development;Ocena roli wybranych czynników ryzyka w rozwoju przełyku Barretta

Polski Merkuriusz Lekarski

Volumn 26, Issue 155, 2009, Pages 390-394

  Kiciński, Przemysław ^a,c   Mokrowiecka, Anna ^b   Czkwianianc, Elzbieta ^a,b,c   Kolasa Kicińska, Marzena ^a,c   Woźniakowska Gesicka, Teresa ^a,c   Małecka Panas, Ewa ^a,b,c  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Polish Mother's Memorial Hospital   (Poland)

Author keywords

Barrett's esophagus; Risk factors

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOPSY; COMORBIDITY; DISEASE COURSE; DRINKING BEHAVIOR; DYSPHAGIA; EPIDEMIOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; FEEDING BEHAVIOR; FEMALE; HEARTBURN; HUMAN; INCIDENCE; LIFESTYLE; MALE; MIDDLE AGED; NAUSEA; OBESITY; PATHOLOGY; QUESTIONNAIRE; RISK FACTOR; SEX RATIO; SMOKING;

ADENOCARCINOMA; ADULT; AGED; ALCOHOL DRINKING; BARRETT ESOPHAGUS; BIOPSY; CAUSALITY; COMORBIDITY; DEGLUTITION DISORDERS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOOD HABITS; HEARTBURN; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; NAUSEA; OBESITY; OVERWEIGHT; QUESTIONNAIRES; RISK FACTORS; SEX DISTRIBUTION; SMOKING;

EID: 67949097450     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Abramus J.A., Fields S., Lightdale Ch.J. i wsp.: Racial and Ethnic Disparities in the Prevalence of Barrett's Esophagus Among Patients Who Undergo Upper Endoscopy. Clin. Gastroenterol. Hepatol., 2008, 6, 1, 30-34.
2. Anderson LA., Watson RG.P. Murphy S.J. i wsp.: Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: Results from the FINBAR study. World J. Gastroenterol., 2007, 13, 10, 1585-1594.
3. Banki F., DeMeester S.R., Mason R.J. i wsp.: Barrett's Esophagus in Females: A Comparative Analysis of Risk Factors in Females and Males. Am. J. Gastroenterol., 2005, 100, 3, 560-567.
4. Bersentes K., Fass R., Padda S. i wsp.: Prevalence of Barrett's esophagus in Hispanics is similar to Caucasians. Dig. Dis. Sci., 1998, 43, 5, 1038-1041.
5. Bu X., Ma Y., Dre R. i wsp.: Body Mass Index is Associated with Barrett Esophagus and Cardiac Mucosal Metaplasia. Dig. Dis. Sci., 2006, 51, 9, 1589-1594.
6. Bukowska L, Korzonek M., Szmattoch E.: Choroba refluksowa przełyku-problemy diagnostyki i terapii. Przeglad Lekarski, 2002, 59, 2, 98-103.
7. Cameron A.J.: Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol. Clin. North Am., 1997, 26, 3, 487-494.
8. Cameron A.J., Lomboy C.T.: Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology, 1992,103,4,1241-1245.
9. Falk G.W.: Barrett's Esophagus. Gastroenterology, 2002, 122, 6, 1569-1591.
10. Ford A.C., Forman D., Reynolds P.D. i wsp.: Ethnicity, Gender, and Socioeconomic Status as Risk Factors for Esophagitis and Barrett's Esophagus. Am. J. Epidemiol., 2005, 162, 5, 454-460.
11. Johansson J., Hakansson H.O., Mellblom L i wsp.: Risk factors for Barrett's oesophagus: A population-based approach. Scand. J. Gastroenterol., 2007, 42, 2, 148-156.
12. Mach T., Zahradnik-Bilska J.: Przełyk Barretta-rozpoznanie i leczenie. Przeglad Lekarski, 1999, 56, 3, 216-219.
13. Reed P.I., Caygill Ch.P.J., Watson A. i wsp.: The United Kingdom Barrett's Oesophagus Registry (UKBOR)-the first six years. Gastroenterol. Pol., 2003, 10,4,299-304.
14. Rex D.K., Cummings O.W., Shaw M. i wsp.: Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology, 2003, 125, 6, 1670-1677.
15. Ronkainen J., Aro P., Storskrubb T. i wsp.: Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology, 2005, 129, 6, 1825-1831.
16. Rosotowski M., Kociniak T., Mikołajczyk I. i wsp.: Rak przełyku: ciagle aktualny problem diagnostyczno-terapeutyczny. Gastroenterol. Pol., 2004, 11, 1,51-55.
17. Sampliner R.E., and The Practice Parameters Committee of the American College of Gastroenterology.: Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol., 2002, 97, 8, 1888-1895.
18. Sharma P., McQuaid K., Dent J. i wsp.: A Critical Review of the Diagnosis and Management of Barrett's Esophagus: The AGA Chicago Workshop. Gastroenterology, 2004, 127, 1, 310-330.
19. Veugelers P.J., Porter G.A., Guernesey D.L. i wsp.: Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Diseases of the Esophagus, 2006, 19, 321-328.
20. Włodarczyk J.: Przełyk Barretta-aspekt molekularny. Przeglad Lekarski, 2008, 65, 2, 73-76.
21. Wong A., Fitzgerald R.C.: Epidemiologic Risk Factors for Barrett's Esophagus and Associated Adenocarcinoma. Clin. Gastroenterol. Hepatol., 2005, 3, 1-10.
22. Yeh C, Hsu C.T., Ho A.S. i wsp.: Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected. Dig. Dis. Sci., 1997, 42, 4, 702-706.